NAS, Oncura sign palladium-103 deal

AuntMinnie.com staff writers

Jul 20, 2005

Radiation therapy firm North American Scientific (NAS) and cryotherapy developer Oncura have signed an agreement to distribute NAS' palladium-103 prostate brachytherapy source, Prospera.

The agreement, which begins on September 9 this year and runs for five years, lets Oncura offer its customers an uninterrupted supply of palladium-103 seeds. The seed will be available in the full range of presentation options for brachytherapy programs, according to Chatsworth, CA-based NAS.

By AuntMinnie.com staff writers
July 21, 2005

Related Reading

NAS nets 510(k), July 8, 2005

Nomos acquisition boosts NAS revenues, June 8, 2005

NAS files quarterly 10-Q report, April 18, 2005

NAS gets Nasdaq delisting notice, March 28, 2005

NAS posts record revenues, but loss widens, March 14, 2005

Copyright © 2005 AuntMinnie.com

Scientific illustration showing chemical formulas, molecular structures, and atomic models on purple gradient background

Eckert & Ziegler gets GMP manufacturing authorization for Ac-225

October 28, 2026

PET/CT scan showing axial, sagittal, and coronal views with metabolic activity visualization in yellow and orange

SIIM-CAIMI: 20% of advanced imaging prior auth denials get overturned

October 27, 2026

Explore Innovations at EANM 2026

Explore Innovations at EANM 2026

October 1, 2026

Research presentation on nuclear medicine fragmentation showing 25 studies with PET imaging criteria analysis and expert interview

EANM: Is ‘research fragmentation’ holding back nuclear medicine?

October 21, 2026

Eckert & Ziegler gets GMP manufacturing authorization for Ac-225

By AuntMinnieEurope.com staff writers

The firm is also planning Ac-225 production at its joint venture facility in China and further expansion in the U.S. and Germany.

October 28, 2026

Scientific illustration showing chemical formulas, molecular structures, and atomic models on purple gradient background

SIIM-CAIMI: 20% of advanced imaging prior auth denials get overturned

By Amerigo Allegretto

Advanced imaging prior authorization denials are overturned at a rate of five times that of all Medicare Advantage services.

October 27, 2026

PET/CT scan showing axial, sagittal, and coronal views with metabolic activity visualization in yellow and orange

AdvanCell reports data on Pb-212 PSMA therapy

By AuntMinnie.com staff writers

Eighty percent of patients had a prostate-specific antigen (PSA) decline of at least 50%, according to the company.

October 26, 2026

Medical illustration of prostate gland surrounded by red cancer cells on blue background

EANM: Is ‘research fragmentation’ holding back nuclear medicine?

Well-designed studies require collaboration among nuclear medicine, medical oncology, urology, radiation oncology, and clinical trial support.

October 21, 2026

Research presentation on nuclear medicine fragmentation showing 25 studies with PET imaging criteria analysis and expert interview

Telix posts revenue growth in Q3

By AuntMinnie.com staff writers

For the period (end-September 30), Telix had group revenues of $245 million, up from $206 million in the same period last year.

October 21, 2026

Business analyst examining financial data charts and percentages through magnifying glass on laptop screen

GEHC begins global clinical evaluation of StarGuide GX SPECT/CT

By AuntMinnie.com staff writers

Participating sites include health centers in the U.S., Europe, and Asia.

October 20, 2026

GE HealthCare CT scanner with gray housing, purple accent ring, and sliding patient table

FAPI-PET detects more HCC lesions than FDG-PET

Relative to F-18 FDG, F-18 FAPI-PET/CT produced staging changes in 19 of 32 patients undergoing initial staging, including six true upstagings.

October 20, 2026

Comparative PET/CT scan images showing [18F]FAPI and [18F]FDG imaging with MIP projections, fusion views, and CT cross-sections for medical diagnosis

EANM: Thomas Hope on what’s next in FAP-targeted theranostics

The innovations and work being done to optimize FAP agents will likely "spill over" to other targets.

October 19, 2026

Clinical research presentation slide showing FAP RLT experience data table with patient outcomes across multiple institutions and speaker photo

Nuclidium, NorthStar sign Cu-67 supply and manufacturing deal

By AuntMinnie.com staff writers

Cu-67 is the therapeutic half of Nuclidium’s theranostic platform, which pairs it with copper-61 (Cu-61) for diagnostic imaging.

October 19, 2026

Hand holding glowing atom symbol with blue and gold light effects against blurred tech background

EANM: Next-generation PET scanner cuts imaging time to one minute

The scanner's fastest images were rated more highly on average than those from a standard PET/CT scanner.

October 18, 2026

PET scan comparison showing SAFOV baseline and 1-minute and 5-minute time-point imaging with tracer uptake patterns

Capitol Imaging Services acquires Impression Imaging

By AuntMinnie.com staff writers

CIS said the deal is part of its expansion into molecular imaging and theranostics.

October 16, 2026

Two businessmen in suits shaking hands during a professional meeting

IBA gets order for 12 cyclotrons for U.S. PET tracer network

By AuntMinnie.com staff writers

A KIUBE 300 system typically costs between €2.5 million and €5 million.

October 16, 2026

Page 1 of 637